Weakness and Quadriparesis
Summary:
Quadriparesis is found among people with Weakness, especially for people who are female, 30-39 old.
The study analyzes which people have Quadriparesis with Weakness. It is created by eHealthMe based on reports of 15 people who have Weakness from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Weakness?
Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.
What is Quadriparesis?
Quadriparesis (muscle weakness affecting all four limbs) is found to be associated with 189 drugs and 695 conditions by eHealthMe. Check the latest studies of Quadriparesis.
15 people who have Weakness and Quadriparesis are studied.

Gender of people who have Weakness and experienced Quadriparesis *:
- female: 100 %
- male: 0.0 %
Age of people who have Weakness and experienced Quadriparesis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 92.86 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 7.14 %
Common co-existing conditions for these people *:
- Pain: 14 people, 93.33%
- Headache (pain in head): 14 people, 93.33%
- Rashes (redness): 13 people, 86.67%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 13 people, 86.67%
- Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain): 13 people, 86.67%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 33.33%
- Psychomotor Skills Impaired: 1 person, 6.67%
- Fatigue (feeling of tiredness): 1 person, 6.67%
- Fainting (loss of consciousness and postural tone): 1 person, 6.67%
- Dysthymia (mild chronic depression): 1 person, 6.67%
Common drugs taken by these people *:
- Sertraline: 12 people, 80.00%
- Pantoprazole: 11 people, 73.33%
- Ginkgo Biloba: 8 people, 53.33%
- Oxycodone: 6 people, 40.00%
- Diazepam: 5 people, 33.33%
- Gabapentin: 5 people, 33.33%
- Carbamazepine: 5 people, 33.33%
- Levothyroxine Sodium: 5 people, 33.33%
- Buprenorphine: 5 people, 33.33%
- Fentanyl: 5 people, 33.33%
Common symptoms for these people *:
- Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 14 people, 93.33%
- Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations): 14 people, 93.33%
- Diplopia (double vision): 14 people, 93.33%
- Disturbance In Attention: 14 people, 93.33%
- Dizziness: 14 people, 93.33%
- Fainting (loss of consciousness and postural tone): 14 people, 93.33%
- Feeling Abnormal: 14 people, 93.33%
- Stress And Anxiety: 14 people, 93.33%
- Loss Of Consciousness: 14 people, 93.33%
- Depression: 14 people, 93.33%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Quadriparesis?
- Check whether Quadriparesis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Weakness (586,876 reports)
- Quadriparesis (2,090 reports)
All the drugs that are associated with Quadriparesis:
- Quadriparesis (189 drugs)
All the conditions that are associated with Quadriparesis:
- Quadriparesis (695 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Quadriparesis and Weakness, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Periogard and Excessive Sleepiness for Women aged 60+ - 4 seconds ago
- Periogard and Sleep - Too Much for Women aged 60+ - 4 seconds ago
- Periogard and Sleep Disorders for Women aged 60+ - 4 seconds ago
- Periogard and Sleep Disorder Therapy for Women aged 60+ - 5 seconds ago
- Periogard and Sleep Disorder Due To General Medical Condition, Insomnia Type for Women aged 60+ - 5 seconds ago
- Periogard and Sleep Disorder Due To A General Medical Condition for Women aged 60+ - 5 seconds ago
- Periogard and Sleep Disorder for Women aged 60+ - 5 seconds ago
- Chlorpromazine Hydrochloride vs. Clonidine, side effect and effectiveness comparison - 10 seconds ago
- Crestor vs. Clopidogrel, side effect and effectiveness comparison - 15 seconds ago
- Oral Pain and drugs of ingredients of daunorubicin hydrochloride - 19 seconds ago